Fucoxanthin structure
|
Common Name | Fucoxanthin | ||
|---|---|---|---|---|
| CAS Number | 3351-86-8 | Molecular Weight | 676.922 | |
| Density | 1.1±0.1 g/cm3 | Boiling Point | 786.5±60.0 °C at 760 mmHg | |
| Molecular Formula | C42H58O6 | Melting Point | 166-168ºC | |
| MSDS | Chinese USA | Flash Point | 228.5±26.4 °C | |
| Symbol |
GHS02, GHS07 |
Signal Word | Danger | |
Use of FucoxanthinFucoxanthin is a marine carotenoid and shows anti-obesity, anti-diabetic, anti-oxidant, anti-inflammatory and anticancer activities. |
| Name | fucoxanthin |
|---|---|
| Synonym | More Synonyms |
| Description | Fucoxanthin is a marine carotenoid and shows anti-obesity, anti-diabetic, anti-oxidant, anti-inflammatory and anticancer activities. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.1±0.1 g/cm3 |
|---|---|
| Boiling Point | 786.5±60.0 °C at 760 mmHg |
| Melting Point | 166-168ºC |
| Molecular Formula | C42H58O6 |
| Molecular Weight | 676.922 |
| Flash Point | 228.5±26.4 °C |
| Exact Mass | 676.433899 |
| PSA | 96.36000 |
| LogP | 7.70 |
| Vapour Pressure | 0.0±6.2 mmHg at 25°C |
| Index of Refraction | 1.563 |
| InChIKey | SJWWTRQNNRNTPU-ABBNZJFMSA-N |
| SMILES | CC(=O)OC1CC(C)(C)C(=C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C(=O)CC23OC2(C)CC(O)CC3(C)C)C(C)(O)C1 |
| Storage condition | ?20°C |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATAMUTATION DATA
|
| Symbol |
GHS02, GHS07 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H225-H319 |
| Precautionary Statements | P210-P280-P305 + P351 + P338-P337 + P313-P403 + P235 |
| Hazard Codes | F |
| Risk Phrases | 11 |
| Safety Phrases | 7-16 |
| RIDADR | NONH for all modes of transport |
| Precursor 0 | |
|---|---|
| DownStream 1 | |
|
Fucoxanthin induces apoptosis in human cervical cancer cell line HeLa via PI3K/Akt pathway.
Tumour Biol. 35(11) , 11261-7, (2014) Cervical cancer (CC) is a malignant neoplasm arising from cells originating in the cervix uteri, among the top causes of death from cancer in women. In a gene expression profiling study of metabolic r... |
|
|
Biological Properties of Fucoxanthin in Oil Recovered from Two Brown Seaweeds Using Supercritical CO2 Extraction.
Mar. Drugs 13 , 3422-42, (2015) The bioactive materials in brown seaweeds hold great interest for developing new drugs and healthy foods. The oil content in brown seaweeds (Saccharina japonica and Sargassum horneri) was extracted by... |
|
|
The anti-apoptotic effect of fucoxanthin on carbon tetrachloride-induced hepatotoxicity.
J. Toxicol. Sci. 38(1) , 115-26, (2013) This study evaluated the anti-apoptotic activity of fucoxanthin in carbon tetrachloride (CCl(4))-induced hepatotoxicity. An in vitro study using the 3-(4,5-dimethylthiazol-2-yl) 2,5-diphenyltetrazoliu... |
| [(1S,3R)-3-hydroxy-4-[(3E,5E,7E,9E,11E,13E,15E)-18-[(1R,3S,6S)-3-hydroxy-1,5,5-trimethyl-7-oxabicyclo[4.1.0]heptan-6-yl]-3,7,12,16-tetramethyl-17-oxooctadeca-1,3,5,7,9,11,13,15-octaenylidene]-3,5,5-trimethylcyclohexyl] acetate |
| β,β-Caroten-8-one, 3'-(acetyloxy)-6',7'-didehydro-5,5',6,6',7,8-hexahydro-3,5,5',6-tetrahydroxy-, (3S,3'S,5R,5'R,6S,6'R,8'R)- |
| MFCD01745140 |
| (3S,3'S,5R,5'R,6S,6'R,8'R)-3,5,5',6-Tetrahydroxy-8-oxo-6',7'-didehydro-5,5',6,6',7,8-hexahydro-β,β-caroten-3'-yl acetate |
| Fucoxanthin |
| Fucoxanthin DISCONTINUED |
| (3S,3'S,5R,5'R,6S,6'R)-3'-(Acetyloxy)-6',7'-didehydro-5,6-epoxy-5,5',6,6',7,8-hexahydro-3,5'-dihydroxy-8-oxo-b,b-carotene |
| (3S,3'S,5R,5'R,6S,6'R)-3'-(acetyloxy)-6',7'-didehydro-5,6-epoxy-5,5',6,6',7,8-hexahydro-3,5'-dihydroxy-8-oxo-β,β-carotene |
| all-trans-Fucoxanthin |